State Medicaid Expansions and Mortality, Revisited: A Cost-Benefit Analysis
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Previous research found that Medicaid expansions in New York, Arizona, and Maine in the early 2000s reduced mortality. I revisit this question with improved data and methods, exploring distinct causes of death and presenting a cost-benefit analysis. Differences-in-differences analysis using a propensity score control group shows that all-cause mortality declined by 6 percent, with the most robust reductions for health-care amenable causes. HIV-related mortality (affected by the recent introduction of antiretrovirals) accounted for 20 percent of the effect. Mortality changes were closely linked to county-level coverage gains, with one life saved annually for every 239 to 316 adults gaining insurance. The results imply a cost per life saved ranging from $327,000 to $867,000 which compares favorably with most estimates of the value of a statistical life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Austin, P. C. (2011) · Pharmaceutical Statistics · doi:10.1002/pst.433 · Cited by 3,949 · cited 2×
“While these differences were smaller for the propensity score control group, several standardized differences still exceeded the threshold of 10% that is one commonly-used goal for propensity score analyses (Austin, 2011).”
MethodResultInfluentialThe Oregon Experiment — Effects of Medicaid on Clinical Outcomes
Baicker, K., Taubman, S. L., Allen, H. L., Bernstein, M., Gruber, J. H., Newhouse, J. P., Schneider, E. C., Wright, B. J., Zaslavsky, A. M., & Finkelstein, A. N. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1212321 · Cited by 1,150
Cognitive Therapy for the Prevention of Suicide Attempts: A Randomized Controlled Trial
Brown, G. K., Ten Have, T., Henriques, G. R., Xie, S. X., Hollander, J. E., & Beck, A. T. (2005) · JAMA · doi:10.1001/jama.294.5.563 · Cited by 1,045
Estimated deaths attributable to social factors in the United States
Galea, S., Tracy, M., Hoggatt, K. J., DiMaggio, C., & Karpati, A. (2011) · American Journal of Public Health · doi:10.2105/ajph.2010.300086 · Cited by 606
Card, D., Dobkin, C., & Maestas, N. (2009) · Quarterly Journal of Economics · doi:10.1162/qjec.2009.124.2.597 · Cited by 494 · cited 1×
“…the elderly have found mixed results: analysis of the 1965 introduction of Medicare did not find any mortality change (Finkelstein & McKnight, 2008), while a regression discontinuity analysis of more recent data detected a reduction in in-hospital deaths at age 65 (Card, Dobkin, & Maestas, 2009).”
ResultPublic Insurance and Mortality: Evidence from Medicaid Implementation
Goodman-Bacon, A. (2018) · Journal of Political Economy · doi:10.1086/695528 · Cited by 270 · cited 2×
“…selection confers an additional 25% mortality risk, 21 this would imply an individual-level mortality reduction from gaining insurance of 38%, consistent with several prior estimates (Goodman-Bacon, 2013; Hadley, 2003; Wilper et al., 2009) from the admittedly conflicting literature on the topic.”
BackgroundResult
Cited by
Medicaid and Mortality: New Evidence From Linked Survey and Administrative Data
Miller, S., Johnson, N., & Wherry, L. R. (2021) · The Quarterly Journal of Economics · doi:10.1093/qje/qjab004 · Cited by 278
Venkataramani, A. S., Bair, E. F., O’Brien, R. L., & Tsai, A. C. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.5686 · Cited by 168
Improving the prognosis of health care in the USA
Galvani, A. P., Parpia, A. S., Foster, E. M., Singer, B. H., & Fitzpatrick, M. C. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33019-3 · Cited by 138
Access to Health Care and Criminal Behavior: Short-Run Evidence from the ACA Medicaid Expansions
Vogler, J. (2017) · SSRN Electronic Journal · doi:10.2139/ssrn.3042267 · Cited by 18
Metadata
- Authors
- Sommers, B. D.
- Venue
- American Journal of Health Economics
- Publisher
- University of Chicago Press
- Published
- 2017-07
- Volume
- 3
- Issue
- 3
- Pages
- 392-421
- ISSN
- 2332-3493 (ISSN-L)
- 2332-3507
- OpenAlex
- W2461940452
- Cited by
- 78
- References
- 6
- FWCI
- 21.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: State Medicaid Expansions and Mortality, Revisited: A Cost-Benefit Analysis. https://app.cochat.ai/papers/10.1162/ajhe_a_00080
- The paper
- Sommers, B. D. (2017). State Medicaid Expansions and Mortality, Revisited: A Cost-Benefit Analysis. American Journal of Health Economics. https://doi.org/10.1162/ajhe_a_00080
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.